Skip to main content
. 2024 May 13;45(35):3254–3269. doi: 10.1093/eurheartj/ehae322

Figure 2.

Figure 2

Effect of semaglutide vs. placebo on loop diuretic dose from baseline to 52 weeks, pooled across the STEP-HFpEF and STEP-HFpEF-DM trials. Error bars represent standard deviations. There was no significant difference in baseline loop diuretic dose between the semaglutide and placebo groups (P = .19)